PRA International Chairs Session on Post Marketing Saf...( RALEIGH N.C. Sept. ...),Health

RALEIGH, N.C., Sept. 10 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will chair and present at a session during the Third Annual World Drug Safety Congress to be held in London on 16-17 September, 2009. The Congress is a gathering of leading Safety, Risk Management and Pharmacovigilance professionals. On 16 September, Dr. Sabine Richter, PRA's Vice President of Safety and Risk Management, will chair a session on Post Marketing Safety Strategy. In this session, Mark Nelson Tyrrell, BS, RPh, Director, Safety and Risk Management at PRA, will present: Post-Marketing Safety Surveillance Design: Choices and Implementation.

Mr. Tyrrell has over 15 years experience in pharmacovigilance in both Pharma and the CRO industry. With over 16 years of industry experience, Dr. Richter has led PRA's Safety and Risk Management group since 2004. Under Dr. Richter's leadership, PRA opened a new Drug Safety Center in Sao Paulo, Brazil in May of 2009, complementing its existing centers in the US and Germany. PRA's Safety and Risk Management team offers comprehensive services throughout a product's life cycle. PRA provides services to support EU-RMP, FDA-REMS, Annual Safety Reporting, IND Reports and a host of other services. In 2008 alone, PRA processed over 18,000 individual safety reports, submitted 3,000 expedited safety reports to regulatory authorities and contributed to 3 FDA approvals for its clients.

About PRA International

PRA International conducts clinical trials in more than 65 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 36 global offices.

PRA's therapeutic expe
'/>"/>